Intellinetics
INLX
9 hedge funds and large institutions have $4.17M invested in Intellinetics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
80% more capital invested
Capital invested by funds: $2.32M → $4.17M (+$1.85M)
3.29% more ownership
Funds ownership: 4.39% → 7.68% (+3.3%)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
+$1.34M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$475K |
| 3 |
BlackRock
New York
|
+$80.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$853 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$39 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.16K |
INLX Hedge Fund Activity: Q2 2025 in Review
9 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Intellinetics (INLX) for Q2 2025, worth a combined $4.17M — up 80% from $2.32M a quarter earlier.
Fund positioning in INLX was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 0 trimmed.
The largest buyer was Bard Associates, adding an estimated $1.34M. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5.16K sold.
- 9 institutional investors held Intellinetics (INLX) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $4.17M of Intellinetics stock for Q2 2025, up 80% quarter-over-quarter.
- 1 fund opened new Intellinetics positions in Q2 2025 and 1 closed out, a net change of 0 holders.
- The largest Intellinetics buyer in Q2 2025 was Bard Associates, an estimated $1.34M added.
- The largest Intellinetics seller in Q2 2025 was Tower Research Capital (TRC), an estimated $5.16K sold.
Based on aggregated 13F filings for Q2 2025.